<< Back to Team Pages
- To design and create a novel leukemia therapeutic using DNA origami techniques and existing methods.
- To translate the process described by Ding et al. to a leukemia cell model using the intercalating drug daunorubicin.
- To develop the ability to circumvent multiple-drug resistance in b-cell malignancies.